Core Viewpoint - Clear Medical (01406.HK) has established itself as the only ophthalmic center in Hong Kong offering a comprehensive advanced refractive treatment portfolio, solidifying its technological leadership in the market [1] Group 1: Company Performance - The company has continued to provide high-quality ophthalmic medical services over the past few months [1] - After a period of slightly weak performance, operational metrics began to recover by the end of 2025, with December seeing patient visits, new patient appointments, and surgical volumes reaching or exceeding levels from the same period in the past two years [1] - The company ranked first in Hong Kong for ICL surgeries in 2025, marking its third consecutive year as the industry leader [1] Group 2: Strategic Developments - The company is set to officially launch the SILK refractive surgery platform in collaboration with Johnson & Johnson in November 2025 [1] - The introduction of the SILK platform enhances the company's offerings, which include LASIK, SMILE, SMILEPro, SILKTM, and ICL [1]